IKKε Knockout Prevents High Fat Diet Induced Arterial Atherosclerosis and NF-κB Signaling in Mice

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Cao, Changchun ^a   Zhu, Yifan ^a   Chen, Wen ^a   Li, Liangpeng ^a   Qi, Yongchao ^a   Wang, Xiaodi ^a   Zhao, Ye ^a   Wan, Xin ^a   Chen, Xin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; AORTA; ATHEROSCLEROSIS; BODY WEIGHT; CELL NUCLEUS; DIET, HIGH-FAT; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; I-KAPPA B KINASE; LIPIDS; MALE; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

MUS;

EID: 84878530506     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064930     Document Type: Article

References (38)

1. Ross R, (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
2. Kutuk O, Basaga H, (2003) Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med 9: 549-557.
3. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, et al. (2008) Endothelial Cell-Specific NF-kB Inhibition Protects Mice from Atherosclerosis. Cell Metab 8: 372-383.
4. Libby P, Okamoto Y, Rocha VZ, Folco E, (2010) Inflammation in Atherosclerosis:Transition From Theory to Practice. Circ J 74: 213-220.
5. Libby P, (2002) Inflammation in atherosclerosis. Nature 420: 868-874.
6. Hansson GK, (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695.
7. Orr AW, Hastings NE, Blackman BR, Wamhoff BR, (2010) Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res 47: 168-180.
8. Niederberger E, Geisslinger G, (2010) Analysis of NF-kappaB signaling pathways by proteomic approaches. Expert Rev Proteomics 7: 189-203.
9. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA, (1997) Role of nuclear factor-kappa B in atherogenesis. Exp Physiol 82: 297-304.
10. Vallabhapurapu S, Karin M, (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
11. Wan F, Lenardo MJ, (2010) The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res 20: 24-33.
12. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
13. Chen LF, Greene WC, (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401.
14. Sun SC, Ley SC, (2008) New insights into NF-kappaB regulation and function. Trends Immunol 29: 469-478.
15. Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, et al. (2003) Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112: 1176-1185.
16. Park SH, Sui Y, Gizard F, Xu J, Rios-Pilier J, et al. (2012) Myeloid-specific IκB kinase β deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 32: 2869-2876.
17. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4: 491-496.
18. Renner F, Moreno R, Schmitz ML, (2010) SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death. Mol Cell 37: 503-515.
19. Tenoever BR, Ng SL, Chua MA, McWhirter SM, García-Sastre A, et al. (2007) Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315: 1274-1278.
20. Qin B, Cheng K, (2010) Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells. Breast Cancer Res 12: R74.
21. Chiang SH, Bazuine M, Lumeng CN, Geletka LM, Mowers J, et al. (2009) The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 138: 961-975.
22. Möser CV, Kynast K, Baatz K, Russe OQ, Ferreirós N, et al. (2011) The protein kinase IKKepsilon is a potential target for the treatment of inflammatory hyperalgesia. J Immunol 187: 2617-2625.
23. Sweeney SE, Hammaker D, Boyle DL, Firestein GS, (2005) Regulation of c-Jun Phosphorylation by the IκB Kinase-ε Complex in Fibroblast-Like Synoviocytes. J Immunol 174: 6424-6430.
24. Pasparakis M, (2009) Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol 9: 778-788.
25. Toby L, (2009) The Nuclear Factor NF-kB Pathway in Inflammation. Cold Spring Harb Perspect Biol 1: 1-10.
26. Bakkar N, Guttridge DC, (2010) NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev 90: 495-511.
27. Häcker H, Karin M, (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.
28. Bonizzi G, Karin M, (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288.
29. Wang N, Ahmed S, Haqqi TM, (2005) Genomic Structure and Functional Characterization of the Promoter Region of Human Iκ-B Kinase-related Kinase IKKi/IKKε. Gene 353: 118-133.
30. Zhang SH, Reddick RL, Piedrahita JA, Maeda N, (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
31. Scheja L, Heese B, Seedorf K, (2011) Beneficial effects of IKKε-deficiency on body weight and insulin sensitivity are lost in high fat diet-induced obesity in mice. Biochem Biophys Res Commun 407: 288-294.
32. Reilly SM, Chiang SH, Decker SJ, Chang L, Uhm M, et al. (2013) An inhibitor of the protein kinases TBK1 and IKKε improves obesity-related metabolic dysfunctions in mice. Nat Med 19: 313-321.
33. Olefsky JM, (2009) IKKepsilon: a bridge between obesity and inflammation. Cell 138: 834-836.
34. Urban MB, Schreck R, Baeuerle PA, (1991) NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J 10: 1817-1825.
35. Chen FE, Kempiak S, Huang DB, Phelps C, Ghosh G, (1999) Construction, expression, purification and functional analysis of recombinant NFkappaB p50/p65 heterodimer. Protein Eng 12: 423-428.
36. Janjetovic Z, Zmijewski MA, Tuckey RC, DeLeon DA, Nguyen MN, et al. (2009) 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One 4: e5988.
37. Imai T, Oikawa Y, Shimada A, Oguchi S, Takamiya Y, et al. (2011) Proatherogenic effect of Interleukin-18 is exerted with high-fat diet, but not with normal diet in spontaneously hyperlipidemic mice. J Atheroscler Thromb 18: 1090-1101.
38. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, et al. (2003) Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 100: 4736-4741.